12:00 AM
 | 
Jun 09, 2014
 |  BC Week In Review  |  Company News  |  Deals

Sea Lane Biotechnologies LLC, Astellas deal

Sea Lane granted Astellas' Agensys Inc. subsidiary a non-exclusive, worldwide license to antibodies generated using...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >